CRBU
Caribou Biosciences, Inc.Company with tickers: CRBU
CIK
1619856
CUSIP
142038108
Shares Outstanding
99,180,575
13F Activity (30d)
119 filings
118 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $2,397,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $28,677,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $20,611,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-26,280,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-25,085,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.26 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.26 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |